BioCentury
ARTICLE | Company News

Advanced Accelerator Applications, Dompe deal

August 8, 2011 7:00 AM UTC

Advanced Accelerator received exclusive, worldwide rights to develop and commercialize Dompe's FabOvar. The iodine-131 labeled humanized mAb fragment is in preclinical testing to treat ovarian cancer,...